ERITORAN, A TOLL-LIKE RECEPTOR-4 (TLR4) ANTAGONIST, ATTENUATES TISSUE DAMAGE AFTER HEMORRHAGIC SHOCK AND REPERFUSION INJURY. S. Korff,A. Frank,P. Loughran,D. Williams, Y. Hindawi, S. Darwiche, D. Rossignol, M. Lynn,T. R. BilliarSHOCK(2011)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要